Tvardi Therapeutics, Inc. (TVRD)

NASDAQ: TVRD · Real-Time Price · USD

1.870

+0.035 (1.91%)

At close: Sep 11, 2026, 4:00 PM EDT

1.840

-0.030 (-1.60%)

After-hours: Sep 11, 2026, 7:57 PM EDT

Tvardi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	15.77	20.73	31.61	22.92	21.49
Short-Term Investments	-	10.08	-	-	22.25
Cash & Short-Term Investments	15.77	30.81	31.61	22.92	43.74
Cash Growth	-61.54%	-2.54%	37.94%	-47.60%	-
Prepaid Expenses	1.3	0.73	0.07	3.24	0.37
Total Current Assets	17.07	31.54	31.69	26.16	44.11
Property, Plant & Equipment	0.14	0.2	0.3	0.38	0.46
Other Intangible Assets	0.29	0.32	0.39	0.45	0.51
Long-Term Deferred Charges	-	-	2.81	-	-
Other Long-Term Assets	0.02	0.02	0.02	0.02	0.02
Total Assets	17.52	32.07	35.2	27	45.1

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	4.64	3.22	2.19	1.61	2.41
Accrued Expenses	4.35	7.71	8.08	1.58	1.79
Current Portion of Leases	0.12	0.12	0.1	0.09	0.08
Total Current Liabilities	9.11	11.04	10.37	3.28	4.28
Long-Term Debt	-	-	30.26	-	-
Long-Term Leases	0.02	0.09	0.2	0.28	0.37
Total Liabilities	9.14	11.13	40.83	3.56	4.65

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.01	0.01	0	0.02	0.02
Additional Paid-In Capital	132.08	131.38	1.1	0.76	0.45
Retained Earnings	-123.71	-110.45	-92.24	-62.84	-45.49
Comprehensive Income & Other	-	0.01	-	-	-0.02
Total Common Equity	8.38	20.95	-91.13	-62.06	-45.05
Shareholders' Equity	8.38	20.95	-5.63	23.45	40.45
Total Liabilities & Equity	17.52	32.07	35.2	27	45.1

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	0.15	0.2	30.56	0.37	0.45
Net Cash (Debt)	15.62	30.61	1.05	22.55	43.29
Net Cash Growth	-61.66%	2812.46%	-95.34%	-47.91%	-
Net Cash Per Share	1.66	3.93	0.41	3.54	6.79
Filing Date Shares Outstanding	13.34	9.38	6.4	6.38	6.37
Total Common Shares Outstanding	9.38	9.38	6.4	6.38	6.37
Working Capital	7.96	20.5	21.32	22.88	39.83
Book Value Per Share	0.89	2.23	-14.24	-9.73	-7.07
Tangible Book Value	8.09	20.62	-91.52	-62.51	-45.56
Tangible Book Value Per Share	0.86	2.20	-14.30	-9.80	-7.15

SEC Filings: 10-K · 10-Q